Edesa Biotech, Inc.EDSANASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank21
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-7.91M
↑ 13% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-9.06M
Historical baseline
PeriodValueYoY Change
2025$-7.91M-12.8%
2024$-7.01M+23.9%
2023$-9.22M+49.8%
2022$-18.37M+22.4%
2021$-23.68M-270.0%
2020$-6.40M-126.0%
2019$-2.83M+44.2%
2018$-5.08M+2.8%
2017$-5.22M-6.4%
2016$-4.91M-